WallStreetZenWallStreetZen

NASDAQ: ELTX
Elicio Therapeutics Inc Stock Ownership - Who owns Elicio Therapeutics?

Insider buying vs selling

Have Elicio Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Yekaterina ChudnovskyDirector2023-12-221,213,000$5.81
$7.05MBuy

1 of 1

ELTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ELTX insiders and whales buy or sell their stock.

ELTX Shareholders

What type of owners hold Elicio Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Eisaabc LLC26.78%2,740,978$24.94MInsider
Yekaterina Chudnovsky18.72%1,915,639$17.43MInsider
Jay Venkatesan18.48%1,891,947$17.22MInsider
Itzhak Goldberg16.49%1,687,986$15.36MInsider
Victor F. Ganzi9.56%978,698$8.91MInsider
Vanguard Group Inc1.71%174,894$1.59MInstitution
Gilbert S. Omenn0.78%80,326$730.97kInsider
Cm Management LLC0.49%50,000$455.00kInstitution
Robert Connelly0.46%46,970$427.43kInsider
Geode Capital Management LLC0.43%44,344$403.53kInstitution

1 of 3

ELTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ELTX3.25%92.54%Net Buying
ALVR14.62%85.38%Net BuyingNet Selling
SGMO48.59%17.99%Net SellingNet Selling
GNLX21.54%5.21%Net SellingNet Selling
QTTB47.15%52.85%Net SellingNet Selling

Elicio Therapeutics Stock Ownership FAQ

Who owns Elicio Therapeutics?

Elicio Therapeutics (NASDAQ: ELTX) is owned by 3.25% institutional shareholders, 92.54% Elicio Therapeutics insiders, and 4.21% retail investors. Eisaabc LLC is the largest individual Elicio Therapeutics shareholder, owning 2.74M shares representing 26.78% of the company. Eisaabc LLC's Elicio Therapeutics shares are currently valued at $24.64M.

If you're new to stock investing, here's how to buy Elicio Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.